GAMC
BIIB icon

Garner Asset Management Corp’s Biogen BIIB Stock Holding History

Garner Asset Management Corp’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22
Closed -$3.87K – 173
2025
Q4 		$3.87K Buy
+22
New +$3.59K ﹤0.01% 372
2024
Q1 		– Sell
-22
Closed -$5.23K – 169
2023
Q4 		$5.23K Buy
+22
New +$5.4K ﹤0.01% 290

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Garner Asset Management Corp's BIIB Position: Q1 2026 in Review

Garner Asset Management Corp sold out of Biogen (BIIB) in Q1 2026, closing a stake of 22 shares — an estimated $3.87K sold.

Garner Asset Management Corp first reported a position in BIIB in Q4 2023 and held it in 2 quarters. The position peaked at $5.23K in Q4 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Garner Asset Management Corp reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Garner Asset Management Corp sold 22 Biogen shares in Q1 2026, an estimated $3.87K.
  • Garner Asset Management Corp first reported a position in Biogen in Q4 2023 and held it in 2 quarters.
  • Garner Asset Management Corp's Biogen position peaked at $5.23K in Q4 2023.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Garner Asset Management Corp's 13F filing for Q1 2026, filed 29 Apr 2026.